135 related articles for article (PubMed ID: 29923998)
1. Clinical study on postoperative triple-negative breast cancer with Chinese medicine: Study protocol for an observational cohort trial.
Chen J; Qin Y; Sun C; Hao W; Zhang S; Wang Y; Chen J; Chen L; Ruan Y; Liu S
Medicine (Baltimore); 2018 Jun; 97(25):e11061. PubMed ID: 29923998
[TBL] [Abstract][Full Text] [Related]
2. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
Yao J; Jiao L; Yao Y; Lu Y; Shi J; Li J; Chen P; Xu L; Gong Y
Trials; 2020 Apr; 21(1):309. PubMed ID: 32245480
[TBL] [Abstract][Full Text] [Related]
3. Clinical observation on the effect of Chinese medicine-"TCM formula" intervention on recurrence and metastasis of triple negative breast cancer.
Wang Y; Li JW; Qin YN; Sun CP; Chen JJ; Ruan YY; Chen LX; Liu S; Liu GY
Complement Ther Med; 2020 Aug; 52():102456. PubMed ID: 32951717
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy in conjunction with traditional Chinese medicine for survival of patients with early female breast cancer: protocol for a non-randomized, single center prospective cohort study.
Liu CT; Chen YH; Huang YC; Chen SY; Tsai MY
Trials; 2019 Dec; 20(1):741. PubMed ID: 31847861
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial.
Lo LC; Chen CY; Chen ST; Chen HC; Lee TC; Chang CS
Trials; 2012 Dec; 13():232. PubMed ID: 23206440
[TBL] [Abstract][Full Text] [Related]
6. Treatment of triple-negative breast cancer with Chinese herbal medicine: A prospective cohort study protocol.
Meng H; Peng N; Yu M; Sun X; Ma Y; Yang G; Wang X
Medicine (Baltimore); 2017 Nov; 96(44):e8408. PubMed ID: 29095272
[TBL] [Abstract][Full Text] [Related]
7. A clinical study on the efficacy of Yiqi Huayu Jiedu decoction for reducing the risk of postoperative recurrence and metastasis of gastric cancer: Protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
Wu CE; Xue WW; Zhuang YW; Ding DW; Zhou JY; Liu SL; Wang RP; Shu P
Medicine (Baltimore); 2020 Nov; 99(48):e23417. PubMed ID: 33235121
[TBL] [Abstract][Full Text] [Related]
8. Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
Wang X; Wang SS; Huang H; Cai L; Zhao L; Peng RJ; Lin Y; Tang J; Zeng J; Zhang LH; Ke YL; Wang XM; Liu XM; Chen QJ; Zhang AQ; Xu F; Bi XW; Huang JJ; Li JB; Pang DM; Xue C; Shi YX; He ZY; Lin HX; An X; Xia W; Cao Y; Guo Y; Su YH; Hua X; Wang XY; Hong RX; Jiang KK; Song CG; Huang ZZ; Shi W; Zhong YY; Yuan ZY;
JAMA; 2021 Jan; 325(1):50-58. PubMed ID: 33300950
[TBL] [Abstract][Full Text] [Related]
9. Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.
Yardley DA; Brufsky A; Coleman RE; Conte PF; Cortes J; Glück S; Nabholtz JM; O'Shaughnessy J; Beck RM; Ko A; Renschler MF; Barton D; Harbeck N
Trials; 2015 Dec; 16():575. PubMed ID: 26673577
[TBL] [Abstract][Full Text] [Related]
10. Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients.
Xu L; Li H; Xu Z; Wang Z; Liu L; Tian J; Sun J; Zhou L; Yao Y; Jiao L; Su W; Guo H; Chen P; Liu J
BMC Complement Altern Med; 2012 Aug; 12():112. PubMed ID: 22853619
[TBL] [Abstract][Full Text] [Related]
11. Does a ketogenic diet as an adjuvant therapy for drug treatment enhance chemotherapy sensitivity and reduce target lesions in patients with locally recurrent or metastatic Her-2-negative breast cancer? Study protocol for a randomized controlled trial.
Wang Y; Jing MX; Jiang L; Jia YF; Ying E; Cao H; Guo XY; Sun T
Trials; 2020 Jun; 21(1):487. PubMed ID: 32503654
[TBL] [Abstract][Full Text] [Related]
12. Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial.
Wu S; Zhang L; Li H; Xu J; Jiang C; Sun T
Trials; 2020 May; 21(1):420. PubMed ID: 32448335
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Our Choice: study protocol for a randomized controlled trial for optimal implementation of psoriasis treatment by the integration of Chinese and western medicine.
Sun X; Zhou X; Wei Y; Yang W; Huang N; Ding Y; Hu R; Guo S; Yang C; Weng H; Zhang Y; Chen X; Ding X; Liu L; Yin Q; Wang R; Li X; Li B
Trials; 2020 Mar; 21(1):299. PubMed ID: 32228720
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
[TBL] [Abstract][Full Text] [Related]
16. The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial.
Ji Y; Li S; Zhang X; Liu Y; Lu Q; Li Q; Chen W; Sheng J; Jiang K; Liang H; Sha S; Li M; Chen Z; Zheng P; Wang M; Feng Y; Wang L; Wu H; Liu H; Huang Y; Yin Z; Xue X
Trials; 2020 Oct; 21(1):844. PubMed ID: 33046128
[TBL] [Abstract][Full Text] [Related]
17. Chinese herbal medicine for oesophageal cancer.
Chen X; Deng L; Jiang X; Wu T
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004520. PubMed ID: 26799001
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
Jiang Y; Liu LS; Shen LP; Liu JX; Jiang GN; Gu AQ; Li HC; Li Q; Li HG; Huang PX
Clin Lung Cancer; 2019 Sep; 20(5):e541-e547. PubMed ID: 31230892
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
20. Association Between Use of Traditional Chinese Medicine Herbal Therapy and Survival Outcomes in Patients With Stage II and III Colorectal Cancer: A Multicenter Prospective Cohort Study.
Xu Y; Mao JJ; Sun L; Yang L; Li J; Hao Y; Li H; Hou W; Chu Y; Bai Y; Jia X; Wang J; Shen L; Zhang Y; Wang J; Liu J; Yang Y
J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
